Year: 2022
Type: dissertation
Abstract: This work examines how processes and practices in the risk regulation frameworks of two issues of concern, nanomaterials and pharmaceutical pollutants, could be improved to strike a balance between development (i.e.supporting innovation and growth) and protection (health and environmental safety) in decision-making in circumstances of uncertainty.Issues of concern are policy issues that have been identified and prioritized under the Strategic Approach to International Chemicals Management (SAICM).Nanomaterials and pharmaceuticals are products that are closely linked to industrial innovation and competitiveness within the European Union, but also raise environmental and health concerns and, consequently, economic costs.This work applies a governance approach, focusing particularly on risk governance, to analyse how risk regulation frameworks could be improved to enable better decision-making in the face of uncertainties.Issues of concern are global risks but require decision-making at different levels.Thus the analysis was carried out within a multi-level (national, EU, international) context.Difficulties in the identification of nanomaterials or pharmaceutical pollutants that fall under the scope of relevant legislation or regulatory initiatives and information collection in respect of them are the two 8 main obstacles encountered in the risk regulation of nanomaterials and pharmaceutical pollutants that weaken the quality of decision-making in circumstances of uncertainty.The consequent lack of information hinders proper risk assessment.More detailed requirements under relevant legislative acts or regulatory initiatives to gather information on the prioritized substances are needed.Frameworks that go beyond legislation and include interdisciplinary dialogue among a broad range of social actors should also be established.This calls for new regulatory approaches and tools that formalize such interaction, as well as a change of mindset towards proactive innovation governance.The "by design" approach, the basic idea of which is that health and environmental safety aspects are considered in a timely manner throughout the innovation chain, could provide a decision-making framework that enables interdisciplinary collaboration between different stakeholders.At international level it could work as a frame that contains essential decision-making principles and ensures that they are considered at an early enough stage when issues of concern are assessed.At EU level, the "by design" approach could be incorporated more directly as a product and project-specific tool by incorporating it alongside sustainability aspects in EU "safe and sustainable by design" criteria.Furthermore, the link between technology readiness levels and regulatory readiness levels could be clarified in regulations.A clearer link between the two would enhance the building up of a predictable, innovation-supporting regulatory environment by creating a framework for timely development work in the innovation chain, both by innovators and by regulators, and would also elucidate for regulators their role as proactive actors in the process.
Author: Miettinen, Mirella
Institution: University of Eastern Finland
Language: English
Subfield: Public Administration
Field: Social Sciences
Domain: Social Sciences
Open Access status: green
Funder: Itä-Suomen Yliopisto
OpenAlex ID: W7215542795
